Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization
Authors
Keywords
-
Journal
eLife
Volume 9, Issue -, Pages -
Publisher
eLife Sciences Publications, Ltd
Online
2020-06-23
DOI
10.7554/elife.57877
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of anti‐flavivirus humoral immune response in protection and pathogenesis
- (2020) Arianna Mahely Hurtado‐Monzón et al. REVIEWS IN MEDICAL VIROLOGY
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- The Challenges of Vaccine Development against a New Virus during a Pandemic
- (2020) Michael S. Diamond et al. Cell Host & Microbe
- Rational Vaccine Design in the Time of COVID-19
- (2020) Dennis R. Burton et al. Cell Host & Microbe
- Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
- (2020) Bin Zhang et al. CHEST
- SARS-CoV-2 Vaccines: Status Report
- (2020) Fatima Amanat et al. IMMUNITY
- Could Intravenous Immunoglobulin Collected from Recovered Coronavirus Patients Protect against COVID-19 and Strengthen the Immune System of New Patients?
- (2020) Samir Jawhara INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
- (2020) Chenguang Shen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Deployment of convalescent plasma for the prevention and treatment of COVID-19
- (2020) Evan M. Bloch et al. JOURNAL OF CLINICAL INVESTIGATION
- Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
- (2020) Kelvin Kai-Wang To et al. LANCET INFECTIOUS DISEASES
- Human neutralizing antibodies elicited by SARS-CoV-2 infection
- (2020) Bin Ju et al. NATURE
- Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
- (2020) Dora Pinto et al. NATURE
- Virological assessment of hospitalized patients with COVID-2019
- (2020) Roman Wölfel et al. NATURE
- A serological assay to detect SARS-CoV-2 seroconversion in humans
- (2020) Fatima Amanat et al. NATURE MEDICINE
- News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine
- (2020) Lynne Peeples PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effectiveness of convalescent plasma therapy in severe COVID-19 patients
- (2020) Kai Duan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rapid COVID-19 vaccine development
- (2020) Barney S. Graham SCIENCE
- Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19
- (2020) Accorsi Patrizia et al. TRANSFUSION AND APHERESIS SCIENCE
- Convalescent Plasma: Therapeutic Hope or Hopeless Strategy in the SARS-CoV-2 Pandemic
- (2020) H. Cliff Sullivan et al. TRANSFUSION MEDICINE REVIEWS
- Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
- (2020) Xiuyuan Ou et al. Nature Communications
- Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig
- (2020) Changhai Lei et al. Nature Communications
- Drugs and the renin-angiotensin system in covid-19
- (2020) Jeffrey K Aronson et al. BMJ-British Medical Journal
- COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics
- (2020) Kuldeep Dhama et al. Human Vaccines & Immunotherapeutics
- Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development
- (2020) Ruklanthi de Alwis et al. EBioMedicine
- Development of a Human Antibody Cocktail that Deploys Multiple Functions to Confer Pan-Ebolavirus Protection
- (2019) Anna Z. Wec et al. Cell Host & Microbe
- Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic
- (2019) Marina Caskey et al. NATURE MEDICINE
- The indications and safety of polyvalent immunoglobulin for post-exposure prophylaxis of hepatitis A, rubella and measles.
- (2019) Megan K Young Human Vaccines & Immunotherapeutics
- Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry
- (2019) Yushun Wan et al. JOURNAL OF VIROLOGY
- Anti–Ebola Virus Antibody Levels in Convalescent Plasma and Viral Load After Plasma Infusion in Patients With Ebola Virus Disease
- (2018) Jerry F Brown et al. JOURNAL OF INFECTIOUS DISEASES
- Anti-retroviral antibody FcγR-mediated effector functions
- (2017) Stylianos Bournazos et al. IMMUNOLOGICAL REVIEWS
- Tackling influenza with broadly neutralizing antibodies
- (2017) Davide Corti et al. Current Opinion in Virology
- Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus
- (2016) Anurodh Shankar Agrawal et al. Human Vaccines & Immunotherapeutics
- Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates
- (2016) Qidi Wang et al. ACS Infectious Diseases
- Rapid generation of a human monoclonal antibody to combat Middle East respiratory syndrome
- (2016) Davide Corti et al. Journal of Infection and Public Health
- Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins
- (2014) Sheng-Fan Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Intranasal Vaccination of Recombinant Adeno-Associated Virus Encoding Receptor-Binding Domain of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Spike Protein Induces Strong Mucosal Immune Responses and Provides Long-Term Protection against SARS-CoV Infection
- (2014) L. Du et al. JOURNAL OF IMMUNOLOGY
- The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis
- (2014) John Mair-Jenkins et al. JOURNAL OF INFECTIOUS DISEASES
- Effects of Toll-Like Receptor Stimulation on Eosinophilic Infiltration in Lungs of BALB/c Mice Immunized with UV-Inactivated Severe Acute Respiratory Syndrome-Related Coronavirus Vaccine
- (2014) N. Iwata-Yoshikawa et al. JOURNAL OF VIROLOGY
- Severe Acute Respiratory Syndrome-Associated Coronavirus Vaccines Formulated with Delta Inulin Adjuvants Provide Enhanced Protection while Ameliorating Lung Eosinophilic Immunopathology
- (2014) Yoshikazu Honda-Okubo et al. JOURNAL OF VIROLOGY
- Complete Protection against Severe Acute Respiratory Syndrome Coronavirus-Mediated Lethal Respiratory Disease in Aged Mice by Immunization with a Mouse-Adapted Virus Lacking E Protein
- (2013) C. Fett et al. JOURNAL OF VIROLOGY
- High Titer and Avidity of Nonneutralizing Antibodies against Influenza Vaccine Antigen Are Associated with Severe Influenza
- (2012) Kelvin K. W. To et al. Clinical and Vaccine Immunology
- Primary Severe Acute Respiratory Syndrome Coronavirus Infection Limits Replication but Not Lung Inflammation upon Homologous Rechallenge
- (2012) Candice Clay et al. JOURNAL OF VIROLOGY
- Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus
- (2012) Chien-Te Tseng et al. PLoS One
- Human Monoclonal Antibodies against Highly Conserved HR1 and HR2 Domains of the SARS-CoV Spike Protein Are More Broadly Neutralizing
- (2012) Hatem A. Elshabrawy et al. PLoS One
- How Can HIV-Type-1-Env Immunogenicity Be Improved to Facilitate Antibody-Based Vaccine Development?
- (2011) Per Johan Klasse et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection
- (2011) I. F. Hung et al. CLINICAL INFECTIOUS DISEASES
- Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH- and Cysteine Protease-Independent Fc R Pathway
- (2011) M. Jaume et al. JOURNAL OF VIROLOGY
- A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response upon Challenge
- (2011) M. Bolles et al. JOURNAL OF VIROLOGY
- Nonresolving Inflammation
- (2010) Carl Nathan et al. CELL
- Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes
- (2010) Ana Clara Monsalvo et al. NATURE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now